Galaxy Medicare Ltd vs Vimta Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Galaxy Medicare Ltd is ₹ 18.05 as of 23 Oct 15:30 . The P/E Ratio of Galaxy Medicare Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Vimta Labs Ltd changed from 16.6 on March 2021 to 24 on March 2024 . This represents a CAGR of 9.65% over 4 years The Market Cap of Galaxy Medicare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 355.7 crore on March 2021 to ₹ 985.7 crore on March 2024 . This represents a CAGR of 29.02% over 4 years The Revenue of Galaxy Medicare Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Vimta Labs Ltd is ₹ 75.57 crore as of Jun '24 . The EBITDA of Galaxy Medicare Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Vimta Labs Ltd is ₹ 25 crore as of Jun '24 . The Net Profit of Galaxy Medicare Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Vimta Labs Ltd is ₹ 12.28 crore as of Jun '24 . The Dividend Payout of Galaxy Medicare Ltd changed from 9.72 % on March 2021 to 31.05 % on March 2026 . This represents a CAGR of 21.36% over 6 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 11.52 % on March 2026 . This represents a CAGR of -9.37% over 6 years .

About Galaxy Medicare Ltd

Galaxy Medicare Limited was originally established on July 23, 1992 as a Limited Company in the Mancheshwar Industrial area of Bhubaneswar, Orissa.
The Company commenced its operations in 1992 when the founder, Mr. Dillip Kumar Das, acquired a closed business unit, M/s Cure Aids Private Limited from Odisha Industrial Infrastructure Development Corporation (IDCO) and Odisha State Financial Corporation under the investment promotion, facilitation and aftercare strategy of Industrial Promotion and Investment Corporation of Odisha (IPICOL) and revived the business unit to start manufacturing of Medical Devices such as Plaster of Paris Bandage (POP Bandage), Medical Tapes and Bandages, Other surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, etc.

About Vimta Labs Ltd

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

FAQs for the comparison of Galaxy Medicare Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Galaxy Medicare Ltd or Vimta Labs Ltd?

Market cap of Galaxy Medicare Ltd is 27 Cr while Market cap of Vimta Labs Ltd is 2,096 Cr

What are the key factors driving the stock performance of Galaxy Medicare Ltd and Vimta Labs Ltd?

The stock performance of Galaxy Medicare Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Galaxy Medicare Ltd and Vimta Labs Ltd?

As of October 25, 2026, the Galaxy Medicare Ltd stock price is INR ₹18.05. On the other hand, Vimta Labs Ltd stock price is INR ₹468.95.

How do dividend payouts of Galaxy Medicare Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Galaxy Medicare Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.